nach oben

Erschienen in:

30.06.2017 | Magnetic Resonance

Different patterns of longitudinal brain and spinal cord changes and their associations with disability progression in NMO and MS

verfasst von: Yaou Liu, Yunyun Duan, Jing Huang, Zhuoqiong Ren, Zheng Liu, Huiqing Dong, Florian Weiler, Horst K. Hahn, Fu-Dong Shi, Helmut Butzkueven, Frederik Barkhof, Kuncheng Li

Erschienen in: European Radiology | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

Objective

To investigate the longitudinal spinal cord and brain changes in neuromyelitis optica (NMO) and multiple sclerosis (MS) and their associations with disability progression.

Patients and methods

We recruited 28 NMO, 22 MS, and 20 healthy controls (HC), who underwent both spinal cord and brain MRI at baseline. Twenty-five NMO and 20 MS completed 1-year follow-up. Baseline spinal cord and brain lesion loads, mean upper cervical cord area (MUCCA), brain, and thalamus volume and their changes during a 1-year follow-up were measured and compared between groups. All the measurements were also compared between progressive and non-progressive groups in NMO and MS.

Results

MUCCA decreased significantly during the 1-year follow-up in NMO not in MS. Percentage brain volume changes (PBVC) and thalamus volume changes in MS were significantly higher than NMO. MUCCA changes were significantly different between progressive and non-progressive groups in NMO, while baseline brain lesion volume and PBVC were associated with disability progression in MS. MUCCA changes during 1-year follow-up showed association with clinical disability in NMO.

Conclusion

Spinal cord atrophy changes were associated with disability progression in NMO, while baseline brain lesion load and whole brain atrophy changes were related to disability progression in MS.

Key Points

• Spinal cord atrophy progression was observed in NMO.

• Spinal cord atrophy changes were associated with disability progression in NMO.

• Brain lesion and atrophy were related to disability progression in MS.

Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG (2007) The spectrum of neuromyelitis optica. Lancet Neurol 6:805–815CrossRefPubMed

Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66:1485–1489CrossRefPubMed

Tackley G, Kuker W, Palace J (2014) Magnetic resonance imaging in neuromyelitis optica. Mult Scler

Fujihara K (2011) Neuromyelitis optica and astrocytic damage in its pathogenesis. J Neurol Sci 306:183–187CrossRefPubMed

Lucchinetti CF, Guo Y, Popescu BF, Fujihara K, Itoyama Y, Misu T (2014) The pathology of an autoimmune astrocytopathy: lessons learned from neuromyelitis optica. Brain Pathol 24:83–97CrossRefPubMedPubMedCentral

Lennon VA, Wingerchuk DM, Kryzer TJ et al (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364:2106–2112CrossRefPubMed

Palace J, Leite MI, Nairne A, Vincent A (2010) Interferon Beta treatment in neuromyelitis optica: increase in relapses and aquaporin 4 antibody titers. Arch Neurol 67:1016–1017CrossRefPubMed

Shimizu J, Hatanaka Y, Hasegawa M et al (2010) IFNbeta-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum. Neurology 75:1423–1427CrossRefPubMed

Min JH, Kim BJ, Lee KH (2011) Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder. Mult Scler 18:113–115CrossRefPubMed

10.

Duan Y, Liu Y, Liang P et al (2012) Comparison of grey matter atrophy between patients with neuromyelitis optica and multiple sclerosis: a voxel-based morphometry study. Eur J Radiol 81:e110–e114CrossRefPubMed

11.

Calabrese M, Oh MS, Favaretto A et al (2012) No MRI evidence of cortical lesions in neuromyelitis optica. Neurology 79:1671–1676CrossRefPubMed

12.

Blanc F, Noblet V, Jung B et al (2013) White matter atrophy and cognitive dysfunctions in neuromyelitis optica. PLoS One 7:e33878CrossRef

13.

Liu Y, Wang J, Daams M et al (2015) Differential patterns of spinal cord and brain atrophy in NMO and MS. Neurology 84:1465–1472CrossRefPubMed

14.

Bakshi R, Thompson AJ, Rocca MA et al (2008) MRI in multiple sclerosis: current status and future prospects. Lancet Neurol 7:615–625CrossRefPubMedPubMedCentral

15.

Brownlee WJ, Altmann DR, Alves Da Mota P et al. (2016) Association of asymptomatic spinal cord lesions and atrophy with disability 5 years after a clinically isolated syndrome. Mult Scler

16.

Lukas C, Knol DL, Sombekke MH et al (2015) Cervical spinal cord volume loss is related to clinical disability progression in multiple sclerosis. J Neurol Neurosurg Psychiatry 86:410–418CrossRefPubMed

17.

Schoonheim MM, Hulst HE, Brandt RB et al (2015) Thalamus structure and function determine severity of cognitive impairment in multiple sclerosis. Neurology 84:776–783CrossRefPubMed

18.

Daams M, Weiler F, Steenwijk MD et al. (2014) Mean upper cervical cord area (MUCCA) measurement in long-standing multiple sclerosis: Relation to brain findings and clinical disability. Mult Scler

19.

Polman CH, Reingold SC, Edan G et al (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 58:840–846CrossRefPubMed

20.

Takahashi T, Fujihara K, Nakashima I et al (2006) Establishment of a new sensitive assay for anti-human aquaporin-4 antibody in neuromyelitis optica. Tohoku J Exp Med 210:307–313CrossRefPubMed

21.

Agosta F, Absinta M, Sormani MP et al (2007) In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study. Brain 130:2211–2219CrossRefPubMed

22.

Miller DH, Barkhof F, Berry I, Kappos L, Scotti G, Thompson AJ (1991) Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines. J Neurol Neurosurg Psychiatry 54:683–688CrossRefPubMedPubMedCentral

23.

Smith SM, Zhang Y, Jenkinson M et al (2002) Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage 17:479–489CrossRefPubMed

24.

Patenaude B, Smith SM, Kennedy DN, Jenkinson M (2011) A Bayesian model of shape and appearance for subcortical brain segmentation. Neuroimage 56:907–922CrossRefPubMedPubMedCentral

25.

Smith SM, Jenkinson M, Woolrich MW et al (2004) Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 23:S208–S219CrossRefPubMed

26.

Vrenken H, Vos EK, van der Flier WM et al (2014) Validation of the automated method VIENA: an accurate, precise, and robust measure of ventricular enlargement. Hum Brain Mapp 35:1101–1110CrossRefPubMed

27.

Lukas C, Hahn HK, Bellenberg B et al (2004) Sensitivity and reproducibility of a new fast 3D segmentation technique for clinical MR-based brain volumetry in multiple sclerosis. Neuroradiology 46:906–915CrossRefPubMed

28.

Lukas C, Sombekke MH, Bellenberg B et al (2013) Relevance of spinal cord abnormalities to clinical disability in multiple sclerosis: MR imaging findings in a large cohort of patients. Radiology 269:542–552CrossRefPubMed

29.

Matthews L, Kolind S, Brazier A et al (2015) Imaging surrogates of disease activity in neuromyelitis optica allow distinction from multiple sclerosis. PLoS One 10:e0137715CrossRefPubMedPubMedCentral

30.

Saji E, Arakawa M, Yanagawa K et al (2013) Cognitive impairment and cortical degeneration in neuromyelitis optica. Ann Neurol 73:65–76CrossRefPubMed

31.

Rocca MA, Mesaros S, Pagani E, Sormani MP, Comi G, Filippi M (2010) Thalamic damage and long-term progression of disability in multiple sclerosis. Radiology 257:463–469CrossRefPubMed

32.

Ishikawa M, Matsumoto M, Fujimura Y, Chiba K, Toyama Y (2003) Changes of cervical spinal cord and cervical spinal canal with age in asymptomatic subjects. Spinal Cord 41:159–163CrossRefPubMed

33.

Ciccarelli O, Wheeler-Kingshott CA, McLean MA et al (2007) Spinal cord spectroscopy and diffusion-based tractography to assess acute disability in multiple sclerosis. Brain 130:2220–2231CrossRefPubMed

34.

Valsasina P, Rocca MA, Absinta M et al (2012) Cervical cord FMRI abnormalities differ between the progressive forms of multiple sclerosis. Hum Brain Mapp 33:2072–2080CrossRefPubMed

35.

Naismith RT, Xu J, Tutlam NT et al (2012) Diffusion tensor imaging in acute optic neuropathies: predictor of clinical outcomes. Arch Neurol 69:65–71CrossRefPubMed

Titel: Different patterns of longitudinal brain and spinal cord changes and their associations with disability progression in NMO and MS
verfasst von: Yaou Liu
Yunyun Duan
Jing Huang
Zhuoqiong Ren
Zheng Liu
Huiqing Dong
Florian Weiler
Horst K. Hahn
Fu-Dong Shi
Helmut Butzkueven
Frederik Barkhof
Kuncheng Li
Publikationsdatum: 30.06.2017
Verlag: Springer Berlin Heidelberg
Erschienen in: European Radiology / Ausgabe 1/2018
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI: https://doi.org/10.1007/s00330-017-4921-x

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Different patterns of longitudinal brain and spinal cord changes and their associations with disability progression in NMO and MS